MIMEDX to Host Fourth Quarter and Full Year 2025 Operating and Financial Results Conference Call on February 25
Rhea-AI Summary
MiMedx (Nasdaq: MDXG) will report fourth quarter and full year 2025 operating and financial results after market close on Wednesday, February 25, 2026.
The senior management team will host a webcast and conference call beginning at 4:30 p.m. ET on February 25. A replay will be available on the company website for approximately 30 days.
Positive
- None.
Negative
- None.
News Market Reaction
On the day this news was published, MDXG gained 0.78%, reflecting a mild positive market reaction.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Market Reality Check
Peers on Argus
MDXG is up 0.59% on an earnings-call scheduling headline, while close peers are mixed: MRVI -1.99%, ATNF +2.92%, MAZE -2.11%, NTLA +2.86%, XERS -1.73%. Moves do not point to a unified sector trend.
Previous Conferences,earnings Reports
| Date | Event | Sentiment | Move | Catalyst |
|---|---|---|---|---|
| 2025-10-15 | Q3 2025 call date | Neutral | +2.0% | Announced timing and access details for Q3 2025 earnings call. |
| 2025-07-16 | Q2 2025 call date | Neutral | +6.0% | Scheduled Q2 2025 results release and management webcast with dial-in info. |
| 2025-04-16 | Q1 2025 call date | Neutral | -2.5% | Outlined Q1 2025 results timing and investor access to conference call. |
| 2025-02-05 | FY 2024 call date | Neutral | -0.1% | Provided schedule for Q4 and full-year 2024 earnings release and call. |
| 2024-10-14 | Q3 2024 call date | Neutral | +0.3% | Announced Q3 2024 reporting date and 4:30 p.m. ET webcast details. |
Earnings date announcements for MDXG have typically produced modest moves, with an average same-day change of about 1.14% around prior calls.
Over the last several months, MIMEDX has combined consistent earnings communication with operational updates. Prior conference-call announcements for 2024–2025 quarters, all scheduled for 4:30 p.m. ET with web replays of about 30 days, saw single‑digit percentage moves around the news. Alongside these, the company reported strong Q3 2025 growth in a 10-Q and entered multiple distribution agreements to expand its wound and surgical portfolio. Today’s notice of the Q4 and full-year 2025 call continues that established reporting cadence.
Historical Comparison
In the past five earnings-conference scheduling releases, MDXG moved an average of 1.14%, indicating these announcements have historically led to modest, contained price reactions.
The company has maintained a steady quarterly cadence of earnings calls from Q3 2024 through 2025, with consistent 4:30 p.m. ET webcasts and 30-day replays for investors.
Market Pulse Summary
This announcement sets the schedule for MIMEDX’s fourth quarter and full year 2025 results, with the call on February 25, 2026 at 4:30 p.m. ET and a 30-day replay. Historically, similar earnings-conference notices for MDXG have produced modest price moves, while investors waited for the actual numbers and guidance. Upcoming metrics on sales growth, margins, and cash from the full-year release will be key for assessing the company’s trajectory.
AI-generated analysis. Not financial advice.
MARIETTA, Ga., Feb. 17, 2026 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”) today announced that it will report its operating and financial results for the fourth quarter and full year ended December 31, 2025 after the market close on Wednesday, February 25, 2026. The MIMEDX senior management team will host a webcast and conference call to review its results beginning at 4:30 p.m. Eastern Time on the same day.
The conference call can be accessed using the following information:
Webcast: Click here
U.S. Investors: 877-407-6184
International Investors: 201-389-0877
Conference ID: 13758446
A replay of the webcast will be available for approximately 30 days on the Company’s website at www.mimedx.com following the conclusion of the event.
About MIMEDX
MIMEDX is a pioneer and leader focused on helping humans heal. With more than a decade and a half of helping clinicians manage chronic and other hard-to-heal wounds, MIMEDX provides a leading portfolio of products for applications in the wound care, burn, and surgical sectors of healthcare. The Company’s vision is to be the leading global provider of healing solutions through relentless innovation to restore quality of life. For additional information, please visit www.mimedx.com.
Contact:
Matt Notarianni
Investor Relations
470-304-7291
mnotarianni@mimedx.com
FAQ
When will MiMedx (MDXG) release Q4 and full year 2025 results?
What time is the MiMedx (MDXG) earnings conference call on February 25, 2026?
How can investors access the MiMedx (MDXG) February 25, 2026 webcast and call?
Will MiMedx (MDXG) provide a replay of the February 25, 2026 webcast?
What period do the results reported by MiMedx (MDXG) on February 25, 2026 cover?
